# N.B.Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/n-b-medical

- Industry: Medical Devices & Equipment
- Headquarters: Tokyo, Japan
- Website: www.nbmed-inc.com
- Total disclosed funding: $5.5M
- Latest round: Series B (Mar 5, 2026)
- Investors on record: 8

## About

Based in Tokyo, Japan, and founded in 2021, N.B.Medical Inc., d.b.a. N.B.Medical, operates as a provider of medical devices intended at treating cerebrovascular diseases. In March 2026, N.B.Medical raised JPY 850 million in series B funding from AIST Solutions, Neuroceuticals Inc., Mitsubishi UFJ Capital, Red Capital, Yokowo co., ltd., ANRI, JAFCO Group, and Reazon Holdings. The round was part of a larger JPY 3.35 billion series B funding.

The company provides a wide range of medical devices, such as advanced endovascular devices, digital transformation technology for improved operability, coating technology to suppress thrombus formation, and solutions for vascular endothelial cell adhesion. Additionally, the firm also provides research and development services to improve patient treatment outcomes.

The February 2026 funding will support faster development, simulation refinement, and clinical trial readiness of the company’s devices, enabling earlier deployment and global expansion.

## Funding rounds

- Series B, Mar 5, 2026, $5.5M — JAFCO Group, Mitsubishi UFJ Capital, ANRI, Neuroceuticals Inc., Reazon Holdings, Yokowo co., ltd., AIST Solutions, Red Capital

## Investors

- JAFCO Group (https://capitalatlas.ai/funds/jafco-group) — Series B
- Mitsubishi UFJ Capital (https://capitalatlas.ai/funds/mitsubishi-ufj-capital) — Series B
- ANRI (https://capitalatlas.ai/funds/anri) — Series B
- Neuroceuticals Inc. — Series B
- Reazon Holdings — Series B
- Yokowo co., ltd. — Series B
- AIST Solutions — Series B
- Red Capital (https://capitalatlas.ai/funds/red-capital) — Series B